Beckman Coulter Plans FDA Submissions in May or June for Troponin Test
January 18, 2011
Beckman Coulter Plans FDA Submissions in May or June for Troponin Test
Its time estimate is based on the current status of its clinical trial for the test, including site and patient enrolment, and preliminary myocardial infarction incidence rates observed.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- FDA Approves Roche's Companion Dx and Drug for Melanoma
August 17, 2011 / GenomeWeb Daily News - FDA Issues Guidance on Clinical Studies for PMA Submissions
August 16, 2011 / GenomeWeb Daily News - FDA Releases Draft Guidances on Medical Devices and Biomarkers
August 15, 2011 / GenomeWeb Daily News - Correlogic Developing 'Second Generation' OvaCheck; Seeks Ruling on Quest, LabCorp Licenses
July 8, 2011 / ProteoMonitor - Phosphoproteomic Profiling Suggests Src Inhibitors Useful as Kidney Cancer Treatment
June 3, 2011 / ProteoMonitor